BSEBoard Meeting4d ago · 4 Nov 2026, 04:52 pm
M. K. Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended 30th September 2026 and any other items with the permission of the chairman.
M. K. Proteins Ltd · 543919
✦ AI SummaryResults
M. K. Proteins Ltd has scheduled a Board Meeting on 13/11/2026 to consider and approve the Unaudited Financial Results for the quarter and half year ended 30th September 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
M. K. Proteins Ltd - 543919 - Board Meeting Intimation for Consider And Approve The Un-Audited Financial Results Of The Company For The Quarter And Half Year Ended 30Th September, 2026
Attachments (1)
📄pdf
Download →
881517d6-7b6c-4487-aff3-b2ab3cf9e54c.pdf
View document text
Date: 04/11/2026
To To
The Manager The Manager
Listing Compliance Listing Compliance
Bombay Stock Exchange Limited National Stock Exchange of India
P.J.Towers, Dalal Street, Limited (NSE)
Mumbai-400 001 Exchange Plaza, Bandra Kurla Complex,
Maharashtra, India Bandra East, Mumbai – 400051
SCRIP CODE: 543919 NSE SYMBOL: MKPL
Sub: Intimation of Board Meeting pursuant to regulation 29 of the SEBI(LODR)
Regulations, 2015
Dear Sir/Madam,
Pursuant to Regulation 29 of the SEBI (LODR) Regulations, 2015, we hereby like to inform
you that a meeting of the Board of Directors of the Company will be held on Friday, 13th
November, 2026, inter alia, to consider and approve the following businesses:
1. The Un-audited Financial Results of the Company for the quarter and half year
ended 30th September, 2026;
2. Any other items with the permission of the chairman.
Further, pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations,
2015 and the Company’s Code of Conduct for prevention of Insider Trading (Code), the
“Trading Window” for trading in Equity Shares of the Company will accordingly be re-
opened after 48 hours from the declaration of the aforesaid Un-audited Financial Results.
You are requested to take the above on record.
Thanking you,
Yours Truly,
For M K Proteins Limited
Neha Aggarwal
Company Secretary & Compliance Officer
M. K. Proteins Limited
Naraingarh Road, Village Garnala, Ambala City(Haryana), India - 134003
T : 0171-2679358 I W: www.mkproteins.in I E: compliancemkproteins@gmail.com
CIN : L15500HR2012PLC046239| ISIN : INE964W01021